Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial

Published:2022-10 Issue:10 Volume:10 Page:e1473-e1484
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Watson-Jones Deborah,Changalucha John,Whitworth Hilary,Pinto Ligia,Mutani Paul,Indangasi Jackton,Kemp Troy,Hashim Ramadhan,Kamala Beatrice,Wiggins Rebecca,Songoro Twaib,Connor Nicholas,Mbwanji Gladys,Pavon Miquel A,Lowe Brett,Mmbando Devis,Kapiga Saidi,Mayaud Philippe,de SanJosé Silvia,Dillner Joakim,Hayes Richard J,Lacey Charles J,Baisley Kathy

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Status of HPV vaccine introduction and barriers to country uptake;Gallagher;Vaccine,2018

2. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019;Bruni;Prev Med,2021

3. Routine vaccination coverage—worldwide, 2020;Muhoza;Morb Mortal Wkly Rep,2021

4. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: a systematic review of evidence from clinical trials;Whitworth;Vaccine,2020

5. Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial;Kreimer;J Natl Cancer Inst,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?;Vaccine;2024-10

2. Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study;npj Vaccines;2024-08-13

3. Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease;Vaccine;2024-08

4. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials;Vaccine: X;2024-08

5. Enhancing equity in cervical screening – initiatives to increase screening participation;Current Opinion in Obstetrics & Gynecology;2024-07-22